BrianWilliamLabadieMD

PubMed

• Lung Transplantation for Pulmonary AL Amyloidosis.
  Ehrlich, M., Hughes, M., D'Ovidio, F., Labadie, B., Siegelin, M., Bijou, R., Lentzsch, S., Arcasoy, S.> ;Transplantation Direct. 2024 Mar 1
• Mitotane and the myth of 14 mg/L.
  Ehrlich, M., Fojo, T., Labadie, B., Bates, S.> ;The Lancet. Oncology. 2024 Jan 1
• 1 citations
  Suppression of Tumor Cell Lactate-generating Signaling Pathways Eradicates Murine PTEN/p53-deficient Aggressive-variant Prostate Cancer via Macrophage Phagocytosis.
  Kiranj Chaudagar, Hanna M Hieromnimon, Anne Kelley, Brian Labadie, Jordan Shafran, Srikrishnan Rameshbabu, Catherine Drovetsky, Kaela Bynoe, Ani Solanki, Erica Markiew...> ;Clinical Cancer Research. 2023 Dec 1
• Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosis.
  Kiranj Chaudagar, Hanna M Hieromnimon, Anne Kelley, Brian Labadie, Jordan Shafran, Srikrishnan Rameshbabu, Catherine Drovetsky, Kaela Bynoe, Ani Solanki, Erica Markiew...> ;Biorxiv. 2023 May 23
• 20 citations
  Reversal of Lactate and PD-1-mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate Cancer.
  Kiranj Chaudagar, Hanna M Hieromnimon, Rimpi Khurana, Brian Labadie, Taghreed Hirz, Shenglin Mei, Raisa Hasan, Jordan Shafran, Anne Kelley, Eva Apostolov, Ghamdan Al-E...> ;Clinical Cancer Research. 2023 May 15
• 5 citations
  Requirements for Meaningful Progress in the Therapy of Neuroendocrine Cancers.
  Brian W Labadie, Antonio Tito Fojo> ;JAMA Oncology. 2023 May 1
• 3 citations
  Guidelines for Management of Treatment-Emergent Adverse Events During Rucaparib Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer.
  Brian W Labadie, David S Morris, Alan H Bryce, Robert Given, Jingsong Zhang, Wassim Abida, Simon Chowdhury, Akash Patnaik> ;Cancer Management and Research. 2022 Jan 1
• 12 citations
  Immune Checkpoint Inhibitors for Genitourinary Cancers: Treatment Indications, Investigational Approaches and Biomarkers.
  Brian W. Labadie, Arjun Vasant Balar, Jason J. Luke> ;Cancers. 2021 Oct 28
• 74 citations
  Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma
  Daniel J Olson, Zeynep Eroglu, Bruce Brockstein, Andrew Poklepovic, Madhuri Bajaj, Sunil Babu, Sigrun Hallmeyer, Mario R. Velasco, Jose Lutzky, Emily F. Higgs, Riyue B...> ;Journal of Clinical Oncology. 2021 May 4
• 55 citations
  Targeting Innate Immunity in Cancer Therapy
  Srikrishnan Rameshbabu, Brian W. Labadie, Anna Argulian, Akash Patnaik> ;Vaccines. 2021 Feb 9
• 7 citations
  Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target.
  Riyue Bao, Oliver Surriga, Daniel J Olson, Jacob B. Allred, Carrie Strand, Yuanyuan Zha, Timothy Carll, Brian W. Labadie, Bruno R. Bastos, Marcus O. Butler, David Hogg...> ;Melanoma Research. 2021 Feb 1
• 33 citations
  Randomized phase II trial and tumor mutational spectrum analysis from cabozantinib versus chemotherapy in metastatic uveal melanoma (Alliance A091201)
  Jason J. Luke, Daniel J Olson, Jacob B. Allred, Carrie Strand, Riyue Bao, Yuanyuan Zha, Timothy Carll, Brian W. Labadie, Bruno R. Bastos, Marcus O. Butler, David Hogg,...> ;Clinical Cancer Research. 2020 Feb 15
• 39 citations
  BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma
  Brian W. Labadie, Ping Liu, Riyue Bao, Michael Crist, Ricardo Fernandes, Laura Ferreira, Scott Graupner, Andrew Poklepovic, Ignacio Duran, Saman Maleki Vareki, Arjun V...> ;Journal of Translational Medicine. 2019 Nov 25
• 220 citations
  Reimagining IDO pathway inhibition in cancer immunotherapy via downstream focus on the tryptophan-kynurenine-aryl hydrocarbon axis
  Brian W. Labadie, Riyue Bao, Jason J. Luke> ;Clinical Cancer Research. 2019 Mar 1
• Assessing the Effect of an Intensive 2-Week Surgical Training and Innovation Program for High-School Students
  Jaime Landman, Brian Labadie> ;Journal of Surgical Education.
• 22 citations
  Review of diagnostic, prognostic, and predictive biomarkers in melanoma
  Jacob S. Ankeny, Brian W. Labadie, Jason J. Luke, Eddy C. Hsueh, Jane L. Messina, Jonathan S. Zager> ;Clinical & Experimental Metastasis. 2018 May 2
• 22 citations
  Clinical and molecular features of innate and acquired resistance to anti-PD-1/PD-L1 therapy in lung cancer
  Shalin Shah, Kevin Wood, Brian W. Labadie, Brian Won, Ryan J. Brisson, Theodore Karrison, Thomas A. Hensing, Mark Kozloff, Riyue Bao, Jyoti D. Patel, Jason J. Luke> ;Oncotarget. 2018 Jan 12
• Join now to see all